Delivery Order SPE2DB24D3013-SPE2DB24FFFTU
- Not listed
- This federal contract award, valued at $1,757.20, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4,564,388,095 units of the prescription drug Vyvanse 30 mg capsule. The contract has a completion date of April 25, 2024 and is structured as a Firm Fixed Price Delivery Order, with no set-aside designation used. Amerisourcebergen is a major pharmaceutical distribution company...
- This federal contract award, valued at $1,337.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the provision of 4,568,013,823 units of the prescription medication Vyvanse 30 mg capsules. The contract has an ultimate completion date of April 24, 2025 and is a firm fixed price arrangement. It is not designated as a set-aside contract, indicating open...
- This federal contract award is a $1,075.66 delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,565,392 units of the prescription medication Vyvanse 30 mg capsule. The contract has an ultimate completion date of August 9, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical,...
- This federal contract award, valued at $4,403.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,568,165,601 units of the prescription medication Vyvanse 30 mg capsules. The contract has a firm fixed price and an ultimate completion date of May 8, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,868.93 firm fixed-price delivery order is for the supply of 4,565,639,987 Vyvanse 30 mg capsules. The contract has an ultimate completion date of August 30, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award, valued at $2,006.08, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the provision of 4,567,951,705 units of the medication Vyvanse 30 mg capsules. The contract is not set aside and is a firm fixed-price, non-IDV (Indefinite Delivery Vehicle) award. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery...
- This federal contract award, valued at $2,079.94, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,568,076,036 units of the medication Vyvanse 40 mg capsules. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 30, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The $3,402.18 firm-fixed-price delivery order is for the supply of 4,564,359,532 units of the prescription medication Vyvanse 50 mg capsules. The contract has an ultimate completion date of April 23, 2024. AmerisourceBergen, one of the largest pharmaceutical distribution companies globally, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with...
- This federal contract award, valued at $4,788.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,072,761 units of the prescription medication Vyvanse 30 mg capsules. The award is a delivery order contract with a firm fixed price and an ultimate completion date of April 29, 2025. It is not designated as a set-aside contract, indicating open competition....
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $10,833.45 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,559,778,029 units of Vyvanse 30 mg capsules. The contract has a firm fixed price and an ultimate completion date of January 31, 2023. This award is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999 through November 2026, which...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB24FFFTUDelivery Order
This federal contract award, valued at $2,563.46, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4,564,880,875 units of the prescription drug Vyvanse 30 mg capsules. The contract is a Firm Fixed Price Delivery Order, with a completion date of June 12, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This specific award appears to be a task order under that larger IDC. The contract does not have a set-aside designation, indicating it was awarded through full and open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 6/11/24 |